CSL Limited develops, manufactures and markets human pharmaceutical and diagnostic products derived from human plasma. The Company's products include pediatric and adult vaccines, infection, pain medicine, skin disorder remedies, antivenoms, anticoagulants, and immunoglobulins.

Notification regarding unquoted securities - CSL

Research and Development Investor Briefing

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

CSL Ltd (CSL AU)

Notification regarding unquoted securities - CSL

Research and Development Investor Briefing

Notice of Research and Development Investor Briefing

Notification of cessation of securities - CSL

Executive Arrangements

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)